Aventis Pasteur S.A.

Sanofi Pasteur Global Dengue Vaccine Clinical Program Expanded in Latin America.
Vaccine Weekly; 12/23/2009; 1141 words; ...each dose [2]. Sanofi Pasteur's dengue vaccine research program...for Human Use (ICH). Sanofi Pasteur's tetravalent dengue vaccine is the...Company, Public Health, Sanofi Pasteur, Sanofi-Aventis, Tropical Disease, Vaccines...

Sanofi Chattem
AP Images; 12/21/2009; 254 words; ...speech during the launch of Sanofi Pasteur's new plant, Sanofi's 11th vaccine production plant...world. French drugmaker Sanofi-Aventis SA said Monday, Dec. 21, 2009, it plans to buy U.S. health-care company Chattem...

Video Q&A: Sanofi Pasteur CEO Wayne Pisano Comments on Outlook for Vaccine Business.
Business Wire; 12/18/2009; 628 words; PARIS -- Sanofi-aventis, one of the world's largest diversified healthcare companies...President Vaccines of sanofi-aventis, and CEO of Sanofi Pasteur, comments on the outlook for sanofi-aventis' vaccine business. Use these links...

Other News To Note.
BIOWORLD Today; 12/17/2009; 950 words; ...Mass.-based Biogen Idec's $17.50 per-share tender offer...brand name Xibrom, and InSite's DuraSite technology. o Syntiron...granted Paris-based Sanofi-Aventis Group's Sanofi Pasteur vaccine division exclusive worldwide...

SHANTHA BIOTECHNICS LAUNCHES CHOLERA VACCINE IN INDIA.
AsiaPulse News; 12/16/2009; 625 words; ...large phase III study to evaluate Shanchol's ability to prevent cholera infections...Shantha, was recently acquired by Sanofi Pasteur- the vaccines division of the French drug firm Sanofi-aventis Group. (PTI) cg 16-12 1556